248 related articles for article (PubMed ID: 28467201)
1. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
[TBL] [Abstract][Full Text] [Related]
3. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
4. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register.
Afghahi H; Svensson MK; Pirouzifard M; Eliasson B; Svensson AM
Diabetologia; 2015 Jun; 58(6):1203-11. PubMed ID: 25773403
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
7. Rate of change in renal function and mortality in elderly treated hypertensive patients.
Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
Adamsson Eryd S; Gudbjörnsdottir S; Manhem K; Rosengren A; Svensson AM; Miftaraj M; Franzén S; Björck S
BMJ; 2016 Aug; 354():i4070. PubMed ID: 27492939
[TBL] [Abstract][Full Text] [Related]
10. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
[TBL] [Abstract][Full Text] [Related]
11. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
[TBL] [Abstract][Full Text] [Related]
12. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
[TBL] [Abstract][Full Text] [Related]
13. Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes.
Barzilay JI; Davis BR; Ghosh A; Pressel SL; Rahman M; Einhorn PT; Cushman WC; Whelton PK; Wright JT;
J Diabetes Complications; 2018 Sep; 32(9):830-832. PubMed ID: 30030011
[TBL] [Abstract][Full Text] [Related]
14. Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Chen CC; Kung PT; Li CI; Yang SY; Liu CS; Lin WY; Lee CC; Li TC; Kardia SL
Cardiovasc Diabetol; 2012 Oct; 11():131. PubMed ID: 23083001
[TBL] [Abstract][Full Text] [Related]
15. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
[TBL] [Abstract][Full Text] [Related]
16. Excess Mortality among Persons with Type 2 Diabetes.
Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
[TBL] [Abstract][Full Text] [Related]
17. Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.
Kelly PJ; Clarke PM; Hayes AJ; Gerdtham UG; Cederholm J; Nilsson P; Eliasson B; Gudbjornsdottir S
Diabet Med; 2014 Aug; 31(8):954-62. PubMed ID: 24750341
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes.
Vepsäläinen T; Laakso M; Kantola I; Lehto S; Juutilainen A; Rönnemaa T
J Intern Med; 2012 Dec; 272(6):611-9. PubMed ID: 22891848
[TBL] [Abstract][Full Text] [Related]
20. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
